Company name: Phoenix Bio Pharmaceutical
Description: Developer of pharmaceutical-grade botanical products. The company focuses on acquiring, developing and manufacturing medical delivery systems for human and animal applications of cannabinoid compounds. Through strategically appointed licensees and project partners, it is building a national network of production and distribution facilities in the United States, with a target of international expansion.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Greenwood Village
Country: United States
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Phoenix Life Sciences for an undisclosed amount on January 31, 2017.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: